FERRARI, CAMILLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.666
EU - Europa 2.486
AS - Asia 1.292
SA - Sud America 153
OC - Oceania 43
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.653
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.650
RU - Federazione Russa 1.154
HK - Hong Kong 459
IT - Italia 290
CN - Cina 283
SG - Singapore 283
IE - Irlanda 276
PL - Polonia 254
SE - Svezia 173
BR - Brasile 139
DE - Germania 114
IN - India 111
FI - Finlandia 84
ID - Indonesia 53
JO - Giordania 49
AU - Australia 43
GB - Regno Unito 35
FR - Francia 26
AT - Austria 16
NL - Olanda 12
KR - Corea 11
UA - Ucraina 10
CA - Canada 9
BE - Belgio 8
VN - Vietnam 8
CH - Svizzera 7
ES - Italia 7
JP - Giappone 6
CI - Costa d'Avorio 5
AR - Argentina 4
CZ - Repubblica Ceca 4
MX - Messico 4
PK - Pakistan 4
ZA - Sudafrica 4
EC - Ecuador 3
GR - Grecia 3
IQ - Iraq 3
SA - Arabia Saudita 3
TR - Turchia 3
UZ - Uzbekistan 3
BD - Bangladesh 2
BG - Bulgaria 2
CL - Cile 2
DK - Danimarca 2
HU - Ungheria 2
IL - Israele 2
KZ - Kazakistan 2
PT - Portogallo 2
TW - Taiwan 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
CO - Colombia 1
DO - Repubblica Dominicana 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
MA - Marocco 1
MK - Macedonia 1
NG - Nigeria 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
RS - Serbia 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.653
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.302
Ashburn 417
Hong Kong 398
Dublin 275
Warsaw 252
Fairfield 228
Chandler 217
Singapore 189
Woodbridge 122
Seattle 98
Houston 95
Cambridge 85
Altamura 81
Lawrence 79
Moscow 68
Florence 67
Wilmington 66
Mumbai 61
Ann Arbor 58
Jakarta 53
Hefei 49
Princeton 46
Dearborn 43
Melbourne 43
Helsinki 42
Boston 38
Buffalo 34
Bremen 33
Shanghai 32
Beijing 30
Munich 27
New York 27
San Diego 26
Turku 25
Bengaluru 22
Pune 21
Los Angeles 18
Medford 18
Rome 17
Kent 16
West Jordan 16
Nuremberg 15
Paris 15
Boardman 13
Lappeenranta 13
Seoul 11
Ferrara 10
Frankfurt am Main 9
São Paulo 9
Brussels 8
Falkenstein 8
Guangzhou 7
Yubileyny 7
Dong Ket 6
Falls Church 6
Lambeth 6
Norwalk 6
San Francisco 6
Vienna 6
Abidjan 5
Barcelona 5
Belo Horizonte 5
Misano Adriatico 5
Prato 5
Romola 5
Toronto 5
Zhengzhou 5
Atlanta 4
Bolzano 4
Brooklyn 4
Colombo 4
Dallas 4
Genoa 4
Hillsboro 4
London 4
Milan 4
Portsmouth 4
Recife 4
Wenzhou 4
Zurich 4
Bern 3
Düsseldorf 3
Fiesole 3
Montreal 3
Nanjing 3
Phoenix 3
Prague 3
Ribeirão Preto 3
Rio de Janeiro 3
Salvador 3
Santa Maria A Monte 3
Siena 3
The Dalles 3
Torres 3
Turin 3
Washington 3
Wuhan 3
Afragola 2
Almaty 2
Aparecida 2
Totale 5.144
Salva come PNG Salva come JPEG
Nome #
Clinical and neuroimaging profiles to identify C9orf72-FTD patients and serum Neurofilament to monitor the progression and the severity of the disease 310
Low Florbetapir PET Uptake and Normal Aβ1-42 Cerebrospinal Fluid in an APP Ala713Thr Mutation Carrier 269
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 244
Alzheimer's Disease Progression: Factors Influencing Cognitive Decline 157
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study 148
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study 139
Biomarkers study in atypical dementia: proof of a diagnostic work-up 138
The Games for Older Adults Active Life (GOAL) project for people with mild cognitive impairment and vascular cognitive impairment: A study protocol for a randomized controlled trial 138
Primary Progressive Aphasia: Natural History in an Italian Cohort 133
Italian Frontotemporal Dementia Network (FTD Group-SINDEM): sharing clinical and diagnostic procedures in Frontotemporal Dementia in Italy 128
High Frequency of Crossed Aphasia in Dextral in an Italian Cohort of Patients with Logopenic Primary Progressive Aphasia 126
Imaging and Cognitive Reserve Studies Predict Dementia in Presymptomatic Alzheimer's Disease Subjects. 123
Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia 119
The diagnosis of dementias: a practical tool not to miss rare causes 116
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 116
Rethinking on the concept of biomarkers in preclinical Alzheimer’s disease 113
Influence of apoe genotype and clock t3111c interaction with cardiovascular risk factors on the progression to alzheimer’s disease in subjective cognitive decline and mild cognitive impairment patients 112
Behavioural disorders in Alzheimer's disease: the descriptive and predictive role of brain 18F-fluorodesoxyglucose-positron emission tomography 110
Neurofilament Light Chain and Intermediate HTT Alleles as Combined Biomarkers in Italian ALS Patients 107
Cognitive composites for genetic frontotemporal dementia: GENFI-Cog 107
Alzheimer's Disease CSF Biomarker Profiles in Idiopathic Normal Pressure Hydrocephalus 105
Cerebrospinal fluid biomarkers for dementia: A case of post-lumbar puncture epidural hematoma 105
Linguistic profiles, brain metabolic patterns and rates of amyloid-β biomarker positivity in patients with mixed primary progressive aphasia 104
Challenges in Alzheimer's Disease Diagnostic Work-Up: Amyloid Biomarker Incongruences 101
Long-term use of pharmacological treatment in Alzheimer's disease: a retrospective cohort study in real-world clinical practice 101
Brain functional network integrity sustains cognitive function despite atrophy in presymptomatic genetic frontotemporal dementia 97
The novel PSEN1 M84V mutation associated to frontal dysexecutive syndrome, spastic paraparesis, and cerebellar atrophy in a dominant Alzheimer's disease family 95
Impairment of episodic memory in genetic frontotemporal dementia: A genfi study 95
Dual Effect of PER2 C111G Polymorphism on Cognitive Functions across Progression from Subjective Cognitive Decline to Mild Cognitive Impairment 93
Loss of speech and functional impairment in Alzheimer's disease-related primary progressive aphasia: predictive factors of decline 93
Huntingtin gene intermediate alleles influence the progression from subjective cognitive decline to mild cognitive impairment: A 14-year follow-up study 93
Novel GRN Mutations in Alzheimer's Disease and Frontotemporal Lobar Degeneration 93
Motor and cognitive outcomes of cerebello-spinal stimulation in neurodegenerative ataxia 90
CAG Repeats Within the Non-pathological Range in the HTT Gene Influence Personality Traits in Patients With Subjective Cognitive Decline: A 13-Year Follow-Up Study 89
Apathy in presymptomatic genetic frontotemporal dementia predicts cognitive decline and is driven by structural brain changes 87
Cognitive functioning among patients with diabetic foot 87
Plasma neurofilament light chain as a biomarker of Alzheimer's disease in Subjective Cognitive Decline and Mild Cognitive Impairment 85
No supportive evidence for TIA1 gene mutations in a European cohort of ALS-FTD spectrum patients 85
Progression of Behavioral Disturbances and Neuropsychiatric Symptoms in Patients With Genetic Frontotemporal Dementia 85
The Frequency of Intermediate Alleles in Patients with Cerebellar Phenotypes 84
The effect of cag repeats within the non-pathological range in the htt gene on cognitive functions in patients with subjective cognitive decline and mild cognitive impairment 83
Gender differences in cognitive reserve: implication for subjective cognitive decline in women 83
Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores 82
Temporal order of clinical and biomarker changes in familial frontotemporal dementia 80
Analysis of brain atrophy and local gene expression in genetic frontotemporal dementia 80
A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study 80
Comparison of clinical rating scales in genetic frontotemporal dementia within the GENFI cohort 78
Differential early subcortical involvement in genetic FTD within the GENFI cohort 78
Late-onset Huntington disease: An Italian cohort 77
FDG PET in the differential diagnosis of degenerative parkinsonian disorders: usefulness of voxel-based analysis in clinical practice 76
Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations 75
Data-driven staging of genetic frontotemporal dementia using multi-modal MRI 74
Intermediate alleles of HTT: A new pathway in longevity 73
Parkinson-ALS with a novel MAPT variant 72
The Huntington’s Disease Gene in an Italian Cohort of Patients with Bipolar Disorder 71
Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia 70
GRN Missense Variants and Familial Alzheimer’s Disease: Two Case Reports 69
The complexity of Alzheimer's disease: an evolving puzzle 67
Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia 67
Incomplete penetrance in familial Alzheimer’s disease with PSEN1 Ala260Gly mutation 67
A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia 66
null 63
How can elderly apolipoprotein E ε4 carriers remain free from dementia? 63
Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study 62
Practice effects in genetic frontotemporal dementia and at-risk individuals: a GENFI study 62
The Revised Self-Monitoring Scale detects early impairment of social cognition in genetic frontotemporal dementia within the GENFI cohort 61
Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales 59
Development of a sensitive trial-ready poly(GP) CSF biomarker assay for C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis 59
The CBI-R detects early behavioural impairment in genetic frontotemporal dementia 59
MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia 58
Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort 56
Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia 55
Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study 55
Comparing Cerebellar tDCS and Cerebellar tACS in Neurodegenerative Ataxias Using Wearable Sensors: A Randomized, Double-Blind, Sham-Controlled, Triple-Crossover Trial 55
Network structure and transcriptomic vulnerability shape atrophy in frontotemporal dementia 52
Future perspective and clinical applicability of the combined use of plasma phosphorylated tau 181 and neurofilament light chain in Subjective Cognitive Decline and Mild Cognitive Impairment 49
Structural MRI predicts clinical progression in presymptomatic genetic frontotemporal dementia: findings from the GENetic Frontotemporal dementia Initiative cohort 49
Plasma GFAP, NfL and pTau 181 detect preclinical stages of dementia 46
Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia 46
Structural brain splitting is a hallmark of Granulin-related Frontotemporal Dementia 43
Diagnostic accuracy of research criteria for prodromal frontotemporal dementia 42
Language impairment in the genetic forms of behavioural variant frontotemporal dementia 40
Longitudinal cerebral perfusion in presymptomatic genetic frontotemporal dementia: GENFI results 32
Matching clinical diagnosis and amyloid biomarkers in alzheimer’s disease and frontotemporal dementia 31
CSF glial markers are elevated in a subset of patients with genetic frontotemporal dementia 30
Long Non-Coding RNA Profile in Genetic Symptomatic and Presymptomatic Frontotemporal Dementia: A GENFI Study 29
Prodromal language impairment in genetic frontotemporal dementia within the GENFI cohort 26
Impaired glymphatic system in genetic frontotemporal dementia: a GENFI study 25
NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: a large GENFI study 24
Temporal dynamics predict symptom onset and cognitive decline in familial frontotemporal dementia 20
Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia 15
Totale 7.754
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.792
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.792
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010 0 0 0 0 0 0 0 0 0 0 0 10
2020/2021357 27 36 19 46 13 14 13 22 50 73 17 27
2021/2022315 6 7 17 12 4 24 1 42 13 20 66 103
2022/20231.161 102 233 73 93 66 205 165 56 125 6 23 14
2023/2024910 30 50 76 32 39 84 57 406 23 56 37 20
2024/20254.212 119 434 276 640 1.143 563 61 276 158 135 206 201
Totale 7.754